SHC-transforming protein 1 (p66Shc) (p66Shc)

p66Shc is a 66 kDa isoform of the SHC-transforming protein 1 (SHC1), distinguished by a unique N-terminal collagen homology 2 (CH2) domain. It functions as a critical redox sensor and oxidoreductase that regulates cellular responses to oxidative stress and governs mammalian lifespan [4.1.1, 4.4.3]. Upon activation by stress signals, p66Shc is phosphorylated at Ser36 and translocates to the mitochondrial intermembrane space, where it catalyzes the production of reactive oxygen species (ROS) by transferring electrons from cytochrome c to oxygen [4.1.2, 4.4.1]. This localized ROS generation leads to mitochondrial dysfunction, opening of the permeability transition pore, and initiation of the apoptotic cascade, contributing to the pathogenesis of cardiovascular diseases, diabetic complications, and neurodegeneration [4.2.2, 4.2.4, 4.2.5]. Beyond its pro-apoptotic role, p66Shc modulates signal transduction by inhibiting the Ras/MAPK pathway and promoting Rac1-mediated NADPH oxidase activity [4.3.2, 4.4.2]. Therapeutic strategies targeting p66Shc, such as gene silencing or small-molecule inhibition of its redox activity, aim to mitigate oxidative damage and improve clinical outcomes in chronic inflammatory and degenerative conditions [5.2.4, 6.1.3]. While no direct inhibitors are currently FDA-approved, several agents targeting its regulatory pathways, such as PKCβ inhibitors, are under investigation [4.2.3, 5.2.1].

Other names

SHC1p66ShcASHC-transforming protein 1 isoform p66p66shc

Inhibition of p66Shc-mediated mitochondrial ROS production and pro-apoptotic signaling, often through upstream kinase inhibition, disruption of protein-protein interactions, or gene silencing.